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Abstract To investigate the pathobiological behaviors of
gastric mixed-type (MT) carcinomas and gastric carcino-
genesis, the clinicopathological characteristics of MT
carcinomas were analyzed and compared with intestinal-
type (IT) and diffuse-type (DT) carcinomas. The expression
of Ki-67, caspase-3, p53, fragile histine triad (FHIT),
maspin, extracellular matrix metalloproteinase inducer
(EMMPRIN), vascular growth factor (VEGF), MUC-2, 4,
5AC and 6, CD44, E-cadherin, β-catenin, and phosphory-
lated glycogen synthase kinase 3β-ser
9 (P-GSK3β-ser
9)
was examined on tissue microarrays using immunohisto-
chemistry. It was found that MT carcinomas exhibited large
size, deep invasion, frequent local invasion, and lymph
node metastasis in comparison with IT and DT carcinomas
(p<0.05). All the markers except MUC-5AC showed
higher expression in IT than DT carcinomas (p<0.05).
The expression of maspin, EMMPRIN, VEGF, MUC-4,
and membrane E-cadherin was stronger in MT intestinal
than diffuse component (p<0.05). Immunoreactivities to
Ki-67, EMMPRIN, and VEGF were weaker in IT carcino-
ma than in the MT intestinal portion (p<0.05), while the
opposite was true for CD44, MUC-2, and MUC-6 (p<
0.05). The MT diffuse component displayed a higher
expression of FHIT, VEGF, and P-GSK3β-ser
9 than DT
carcinoma (p<0.05). The accumulative survival rate of the
IT carcinoma patients was higher than the other types (p<
0.05). The invasive depth, venous invasion, lymph node,
peritoneal or liver metastasis, and Lauren's classification
were independent prognostic factors for gastric carcinomas
(p<0.05). These findings suggested that MT carcinomas
were also indicated to be more aggressive than IT and DT
carcinomas. Significant differences were observed in the
proliferation, apoptosis, angiogenesis, mucin secretion, and
cell adhesion between IT and DT carcinomas, whereas only
a few of these characteristics showed differences between
the MT intestinal and diffuse parts, thus suggesting that
both the MT components might originate from the stem
cells with similar genetic traits, but follow different
histogenic pathways.
Keywords Gastriccarcinoma.Mixedtype.Lauren's
classification.Pathobiologicalbehaviors.Carcinogenesis
Introduction
Gastric carcinoma is the second leading cause of cancer-
related death behind lung carcinoma despite a worldwide
decline in both its incidence and mortality since the late half
of the twentieth century [11]. It continues to be a major
health problem because of the slow decrease in incidence in
Asia and high mortality of diagnosed gastric carcinoma in
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gastric carcinoma is somewhat dependent on its histological
type, such as intestinal type (IT) or diffuse type (DT) as
defined by Lauren [16].
Although gastric carcinoma is a malignant tumor
originating from the same gastric epithelium, its morpho-
logical features vary substantially among individual
patients. Histologically, IT carcinoma principally includes
papillary, well-differentiated, and moderately-differentiated
or mucinous adenocarcinoma without signet ring carcinoma
(SRC) cells, whereas DT mainly consists of the SRC,
poorly differentiated and undifferentiated adenocarcinoma
of WHO classification [7, 23]. Although Kushima and
Hattori [12] firstly proposed an entity of gastric-type
carcinoma and terminologically seemed homologous to
the IT one, the carcinoma cells of this type closely resemble
normal foveolar cells on the basis of tissue morphology and
mucin properties and are considered to have been derived
from foveolar hyperplasia or pyloric gland adenoma [12,
13]. Recently, our group also focused on Lauren's classifi-
cation and found that IT carcinoma frequently occurred in
old men, while DT was more frequent in comparatively
young women. The latter group was more inclined to
invasion into the muscularis propria, lymphatic invasion,
and lymph node metastasis, and belonged to a higher TNM
staging, in comparison to its IT counterparts. Further
analysis demonstrated that IT gastric carcinomas with a
more favorable prognosis were prone to high levels of
proliferation and apoptosis and also always accompanied
by a strong expression of the fragile histine triad (FHIT),
phosphatase and tensin homology deleted from human
chromosome 10 (PTEN), p53, and extracellular matrix
metalloproteinase inducer (EMMPRIN) [30]. Additionally,
many genetic and epigenetic changes, such as mutation,
deletion, loss of heterozygosity, methylation, and micro-
satellite instability were differentially observed in both
histological types of gastric carcinoma [27, 36]. These data
indicate that different carcinogenic pathways exist for
gastric IT and DT carcinomas. Although carcinogenesis is
a multistage process which consists of a multi-factorial
etiology resulting from gene–environment interaction, the
intestinal type is frequently related to environmental factors
like diet and predominates in areas with a high incidence of
this disease. In contrast, the diffuse type is thought to be of
genetic origin and evenly distributed worldwide [30, 24]. It
is commonly believed that Lauren's classification is
valuable for both the epidemiological studies and gastric
carcinogenesis.
However, a small number of gastric carcinomas remain
characterized as unclassified or mixed-type (MT) ones,
which are comprised histologically of non-homogenous
mixtures of IT and DT carcinomas. Stelzner and Emmrich
[26] found that 28 MT carcinomas showed a deep
infiltration of the gastric wall, frequent regional lymph
node metastasis, and high staging in comparison to the
other two types. Machado et al. [21] reported that
inactivating E-cadherin mutations were exclusively ob-
served in the diffuse component of the tumors, thus
suggesting that MT carcinomas displayed phenotypic
divergence. A recent study showed that bone-marrow-
derived cells (BMDCs) could progress through metaplasia
and dysplasia to intraepithelial cancer under the induction
of the carcinogen, Helicobacter pylori [9]. Therefore, the
analysis of distinct MT carcinoma components can be of
remarkable pathogenic significance if it would be true that
carcinoma cells originate from BMDCs. In the present
study, 814 cases of gastric carcinomas were collected to
further clarify the pathological characteristics of MT
carcinoma and the gastric carcinogenesis pathways using
a combination of tissue microarray (TMA) and immuno-
histochemical techniques.
Materials and methods
Subjects
A total of 814 gastric carcinomas were collected from
surgical resection in Kouseiren Takaoka Hospital between
1998 and 2006. The patients with carcinomas included 573
men and 241 women (29–91 years, mean=65.7 years).
Among them, 312 cases were demonstrated with lymph
node metastasis and 24 with liver metastasis. None of these
cases underwent either chemotherapy or radiotherapy
before surgery. All patients gave their informed consent
for the use of tumor tissue specimens for clinical research
and the University Ethical Committee approved the
research protocol. All patients were followed up by
consulting their case documents and through telephone
interviews.
Pathology
All tissue specimens were fixed in 4% neutralized formal-
dehyde, embedded in paraffin, and cut into 4-μm sections.
These sections were stained by hematoxylin and eosin (HE)
to confirm their histological diagnosis and other micro-
scopic characteristics. The staging for each gastric carcino-
ma was evaluated according to the TNM system of the
Internationale Contre le Cancer (UICC) indicating the
extent of tumor spread [25]. The histomorphological
architecture of the tumors was expressed according to
Lauren's classification [7, 16, 30]. The growth patterns were
divided into five groups based on a modification of
Emmrich's method [26]. Briefly, group I showed a
combination of two components with diffuse distribution.
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visible. Group III represented some signet cells in the
intestinal and diffuse components. Group IV were mucinous
carcinomas with signet cells. Group V exhibited separately
intestinal and diffuse components in the gastric wall. In
addition, the depth of invasion, lymphatic and venous
invasion, and peritoneal dissemination were all determined.
Tissue microarray
IT and DT carcinomas, as well as both components of the
mixed type, were identified in HE stained sections of the
selected tumor cases and a 2-mm-diameter tissue core of
each donor block was punched out and transferred to a
recipient block with a maximum of 48 cores using a Tissue
Microarrayer (AZUMAYA KIN-1, Tokyo, Japan). Four-
micrometer-thick sections were cut from the recipient block
and transferred to poly-lysine-coated glass slides. HE
staining was performed on TMA for confirmation of the
tumor tissue (Fig. 1).
Immunohistochemistry
Consecutive sections were deparaffinized with xylene,
dehydrated with alcohol, and subjected to antigen retrieval
by irradiating in target retrieval solution (TRS, DAKO,
Carpinteria, UAS) for 15 min in a microwave oven
(Oriental rotor Lmt. Co. Tokyo, Japan). Five percent bovine
serum albumin (BSA) was then applied for 15 min to
prevent non-specific binding. The sections were incubated
with primary antibodies for 15 min, then treated with the
anti-mouse or anti-rabbit Envison-PO (DAKO, USA) anti-
bodies for 15 min. All incubations were performed in the
microwave oven for intermittent irradiation as described
previously [15]. After each treatment, the slides were
washed with TBST (10 mM Tris–HCl, 150 mM NaCl,
0.1% Tween 20) three times for 1 min. The primary
antibodies are summarized in Table 1. All immunostaining
was visualized with 3, 3′-diaminobenzidine (DAB) with 5-
min reaction and counterstained with Mayer's hematoxylin.
Fig. 1 HE staining of TMA of
gastric carcinomas
Table 1 Primary antibodies used in this study
Names Source Company Dilution
Ki-67 Rabbit DAKO, Carpinteria, USA 1:25
Caspase-3 Rabbit DAKO, USA 1:150
p53 Mouse DAKO, USA 1:100
FHIT Rabbit Neomarkers, Fremont, USA 1:200
Maspin Mouse Novocastra, Newcastle
upon Tyne, UK
Read-
to-use
EMMPRIN Mouse Novocastra, UK 1:100
VEGF Rabbit Labvision, Fremont, USA 1:50
P-GSK3β-
ser
9
Rabbit SAT, USA 1:300
MUC-2 Mouse Novocastra, UK 1:100
MUC-4 Mouse Novocastra, UK 1:100
MUC-5AC Mouse Novocastra, UK 1:100
MUC-6 Mouse Novocastra, UK 1:100
CD44 Mouse DAKO, USA 1:50
E-cadherin Mouse Takara, Otsu, Japan 1:100
β-Catenin Mouse Calbiochem, CA, USA 1:200
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control.
The immunoreactivity to Ki-67 and p53 was localized in
the nucleus; FHIT, caspase-3, vascular growth factor
(VEGF), maspin, phosphorylated glycogen synthase kinase
3β-ser
9 (P-GSK3β-ser
9), MUC-2, MUC-5AC, and MUC-6
in the cytoplasm; EMMPRIN and MUC-4 in the cytoplasm
and membrane; CD44 and E-cadherin in the membrane;
and β-catenin in the nucleus, cytoplasm, and membrane
(Fig. 2). All evaluations were performed blindly by two
independent observers (Takano Y and Zheng HC).
Statistical analysis
The statistical evaluation was performed using Fisher's
exact possibility to differentiate the rates and the Mann–
Whitney U test to differentiate the means of the different
groups. Kaplan–Meier survival plots were generated and
comparisons between the survival curves were made with
the log-rank statistic. The Cox proportional hazards model
was employed for multivariate analysis. p<0.05 was
considered to represent a statistically significant difference.
The SPSS 10.0 software program was employed to analyze
all data.
Results
Clinicopathological characteristics of gastric IT, DT,
and MT carcinomas
As summarized in Table 2, 415 IT cases were identified
(51.0%), 221 DT (27.1%), and 178 MT (21.9%) among the
814 gastric carcinomas in this study. Patients with IT
carcinoma were found to be significantly older than those
with DT (p<0.05). The male and female ratios in the
carcinoma cases gradually decreased from IT to DT
through the MT groups (p<0.05). It was the same for
lower TNM staging in the three groups (p<0.05). The
positive rate of peritoneal spread was higher in the DT and
MT cases than IT (p<0.05). MT carcinomas showed
aggressive characteristics, such as large size, deep invasion,
frequent local invasion, and lymph node metastasis,
compared to the IT and DT (p<0.05). There was no
significance between the three types of gastric carcinomas
in the incidence of the liver metastasis (p>0.05).
Pathological behaviors of gastric MT carcinomas
with different growth patterns or histological distribution
of components
According to the growth pattern, the intestinal and diffuse
components diffusely distributed without absolute border in
group I of the MT carcinomas, which occurred more
frequently (60.0%, 106/178) than the other four groups.
As indicated in Table 3, most groups III and V gastric
carcinomas were generally of early stage with less local
invasion, infrequent lymph node metastasis and low TNM
staging. In this study, only four advanced gastric carcino-
mas belonged to group IV, among which three cases were
women and all were accompanied with lymphangiogenic
invasion, lymph node metastasis, and high TNM staging.
Although the main histological component was different
from that in lymph node metastasis, the statistical data
revealed that there was histological consistency between
primary and lymph node metastasis foci (p<0.05). There
were no remarkable differences in the pathological behav-
iors of MT carcinomas with different ratios of intestinal and
diffuse portions (p>0.05).
Immunohistochemical analysis of intestinal or diffuse
components from three types of gastric carcinomas
Table 4 demonstrates that all the markers except MUC-5AC
were expressed at higher levels in IT carcinomas than in MT
ones (p<0.05). The expression of maspin, EMMPRIN,
VEGF, MUC-4, and E-cadherin was stronger in the intestinal
component of MT carcinomas than in their diffuse counter-
part (p<0.05). Immunoreactivities to Ki-67, EMMPRIN, and
VEGF were weaker in the intestinal-type carcinomas than in
the intestinal component of the MT (p<0.05), while it was
the opposite for CD44, MUC-2, and MUC-6 (p<0.05). In
contrast, the diffuse components of the MT carcinomas
showed greater expression of Ki-67, FHIT, VEGF, and P-
GSK3β-ser
9 than DT carcinomas (p<0.05).
Patients' outcome with different gastric carcinomas
Follow-up information for 500 carcinoma patients was used
before 2002 for a period ranging from 5 days to 9.15 years
(mean=49.4 months). Figure 3 shows the survival curves
stratified according to Lauren's classification. Kaplan–Meier
analysis indicated that the patients with IT carcinoma had a
higher cumulative survival rate than those with the DT and
MT lesions (p<0.05). Although the MT carcinoma patients'
survival rate was comparatively lower than the DT ones,
Fig. 2 Immunostaining of TMA of gastric carcinomas. The immuno-
reactivity to Ki-67 (a) and p53 (c) was localized in the nucleus; FHIT
(d), caspase-3 (b), VEGF (g), maspin (e), P-GSK3β-ser
9 (h), MUC-2
(i), MUC-5AC (k), MUC-6 (l) were seen in the cytoplasm,
EMMPRIN (f) and MUC-4 (j) were seen in the cytoplasm and the
plasma membrane, CD44 (m), and E-cadherin (n) in the plasma
membrane; and β-catenin (o) in the nucleus, cytoplasm, and plasma
membrane. These molecules were strongly expressed in the intestinal-
type gastric carcinomas

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analysis demonstrated that invasive depth, venous invasion,
lymph node, peritoneal or liver metastasis, and Lauren's
classification were independent factors for the poor progno-
sis of gastric carcinoma patients (p<0.05; Table 5).
Discussion
Histologically, Lauren's classification of gastric carcinomas
is based on the morphological appearances. IT carcinomas
are characterized by cohesive carcinoma cells forming
gland-like tubular structures with an expanding or infiltra-
tive growth pattern, like a papillary and well-differentiated
adenocarcinoma. However, the cell cohesion is less
apparent or absent in DT carcinomas, and cancer cells
diffusely spread in the gastric wall as poorly differentiated
adenocarcinomas, SRC, or undifferentiated carcinomas [23,
30]. However, there are two types of histological distribu-
tion in the MT carcinoma, as described by Lauren [16]. In
this study, carcinoma diagnosed as MT made up 21.9% of
the whole series in this population, more than that reported
by Borch et al. (13%), Lauren (14%), and Stelzner and
Emmrich (14.1%), and less than that reported by Carneiro
et al. (38.5%) [2, 5, 16, 26]. This discrepancy might be due
to the differences in diagnosis criteria, geographical
regions, human races, living habits, and so forth. The age
and sex distribution of the patients with MT carcinoma was
intermediate although IT carcinomas frequently occurred in
old men, compared with DT carcinomas.
Morphologically, there are both intestinal and diffuse
components in MT carcinomas, and they were found to be
significantly larger, more advanced, and more frequently
spread into local lymphatic and venous vessels or regional
lymph nodes, compared with IT and DT carcinomas in the
present study, consistent with other reports [6, 16, 30].
Kozuki et al. [14] found that prominent lymphatic perme-
ation and lymph node metastasis were more frequently
Table 2 Comparison of the clinicopathological features in gastric IT, DT, and MT carcinomas
Clinicopathological features Intestinal-type carcinoma Diffuse-type carcinoma Mixed-type carcinoma
Case number 415 (51.0%) 221 (27.1%) 178 (21.9%)
Age (mean ± SD, years) 67.09±10.73 62.03±11.3* 65.80±13.28
Sex (male:female) 324:91 125:96 124:54**
Tumor size (mean ± SD, cm) 3.82±3.21 5.50±6.95 5.56±3.08**
Invasion into muscularis propria 153 (36.9%) 121 (54.8%) 123 (69.1%)**
Lymphatic invasion (+) 117 (28.2%) 83 (37.6%) 99 (55.6%)**
Venous invasion (+) 49 (11.8%) 32 (14.5%) 39 (21.9%)**
Lymph node metastasis (+) 113 (27.2%) 94 (42.5%) 105 (59.0%)**
Liver metastasis (+) 10 (2.4%) 8 (3.6%) 6 (3.4%)
Peritoneal spread (+) 14 (3.4%)*** 22 (10.0%) 21 (11.8%)
TNM staging (O, I) 302 (72.8%) 69 (31.2%) 112 (63.0%)**
*p<0.05 compared with intestinal- and mixed-type carcinomas
**p<0.05 compared with intestinal- and diffuse-type carcinomas with both analyzed
***p<0.05 compared with diffuse- and mixed-type carcinomas
Table 3 Pathological behaviors of gastric MT carcinomas
Clinicopathological
features
n Sex (male) Invasion
into MP
Lymphatic
invasion
Venous invasion Lymph node metastasis Staging
n I>D I=D I<D (O, I)
Growth pattern
I 106 73 (68.9%) 82 (77.4%) 64 (60.4%) 26 (24.5%) 69 (65.1%) 32 14 23 35 (33.0%)
II 25 18 (78.3%) 21 (84.0%) 16 (64.0%) 7 (28.0%) 16 (64.0%) 5 5 6 7 (28.0%)
III 29 22 (75.9%) 11 (37.9%) 9 (31.0%) 3 (10.3%) 10 (34.5%) 4 3 3 18 (62.1%)
IV 4 1 (25.0%) 4 (100.0%) 4 (100.0%) 1 (25.0%) 4 (100.0%) 0 2 2 0 (0.0%)
V 14 10 (71.4%) 5 (35.7%) 6 (42.9%) 2 (14.3%) 6 (42.9%) 2 0 4 9 (64.3%)
Histological appearance
Intestinal>diffuse 80 59 (73.8%) 54 (67.5%) 43 (53.8%) 20 (25.0%) 48 (60.0%) 30 8 10 33 (41.3%)
Intestinal=diffuse 20 15 (75.0%) 12 (60.0%) 9 (45.0%) 5 (25.0%) 10 (50.0%) 3 5 2 8 (40.0%)
Intestinal<diffuse 78 50 (64.1%) 57 (73.1%) 47 (60.3%) 14 (18.0%) 47 (60.3%) 10 11 26 28 (35.9%)
MP Muscularis propria; in lymph node metastatic foci: I>D intestinal>diffuse, I<D intestinal<diffuse, I=D intestinal=diffuse
530 Virchows Arch (2008) 452:525–534observed in MT than in the pure type of gastric carcinomas.
It was previously documented that the MT carcinomas
showed a deeper infiltration of the gastric wall, a higher
metastatic rate to the regional lymph nodes, and the need
for higher staging with the TNM system of UICC
classification, in contrast to IT and MT carcinomas [26].
These findings suggest that the pathobiological character-
istics of the MT carcinomas were more aggressive than the
other two types, which accounted for their comparatively
poor prognosis observed in the present study although there
was no statistical significance. Among the MT carcinomas,
five groups were classified according to their growth
pattern. Half of the present cases belonged to group I,
which means there was diffuse distribution of the intestinal
and diffuse component without clear borders in most of the
MT cases. In general, groups III and IV of MT carcinomas
did not exhibit deep invasion, comparatively high staging
or frequent spreading, compared with other types. How-
ever, group IV of carcinomas with mucin and signet cells
was more advanced with wide spreading, including local
vessels and lymph node metastasis. Therefore, surgeons
should carefully treat the patients with MT carcinomas in
clinical practice because of their aggressive characteristics
and poor prognosis, especially those classified as group IV.
Furthermore, it was found that the major component in the
MT primary foci morphologically paralleled to that in the
Table 4 Immunohistochemical analysis in gastric IT, DT, and MT carcinomas
Biological markers Intestinal-type carcinoma Mixed-type carcinoma Diffuse-type carcinoma
Intestinal part Diffuse part
Ki-67 88/146 (60.3%)*
,** 81/110 (73.6%) 78/110 (70.9%)* 57/119 (47.9%)
Caspase-3 84/152 (55.3%)* 52/119 (43.7%) 37/119 (31.1%) 24/115 (20.9%)
p53 76/151 (50.3%)* 37/118 (31.4%) 30/118 (25.4%) 25/120 (20.8%)
FHIT 90/150 (60.0%)* 63/113 (55.8%) 48/113 (42.5%)* 27/116 (23.3%)
Maspin 71/150 (47.3%)* 55/112 (49.1%)*** 34/112 (30.4%) 38/120 (31.7%)
EMMPRIN 87/147 (59.2%)*
,** 77/112 (68.8%)*** 43/112 (38.4%) 32/117 (26.5%)
VEGF 95/151 (62.9%)*
,** 90/114 (78.9%)*** 61/114 (53.5%)* 31/121 (25.6%)
P-GSK3β-ser
9 88/144 (61.1%)* 74/113 (65.5%) 67/113 (59.3%)* 48/116 (41.4%)
MUC-2 55/145 (37.9%)*
,** 31/118 (26.3%) 27/118 (22.9%) 23/117 (19.7%)
MUC-4 58/153 (37.9%)* 39/118 (33.1%)*** 21/118 (17.8%) 18/118 (15.3%)
MUC-5AC 84/148 (56.8%) 57/106 (53.8%) 50/106 (47.2%) 54/113 (47.8%)
MUC-6 60/146 (41.1%)*
,** 26/117 (22.2%) 18/117 (15.4%) 9/123 (7.3%)
CD44 64/152 (42.1%)*
,** 32/114 (28.1%) 31/114 (27.2%) 32/120 (26.7%)
E-cadherin 91/142 (64.1%)* 58/112 (51.8%)*** 38/112 (33.9%) 43/119 (36.1%)
Membrane β-catenin 57/144 (39.6%)* 36/117 (30.8%) 26/117 (22.2%) 26/118 (22.0%)
*p<0.05 compared with the diffuse-type carcinomas
**p<0.05 compared with intestinal-part carcinomas
***p<0.05 compared with diffuse-part carcinomas
Fig. 3 Relationship between
prognosis of carcinoma patients'
and Lauren's classification
Kaplan–Meier curves of cumu-
lative survival rate for the
patients with gastric carcinoma
according to Lauren's classifica-
tion. IT Intestinal type, DT
diffuse type, MT mixed type
Virchows Arch (2008) 452:525–534 531corresponding lymph node metastasis although the con-
verse situation also appeared. This inconsistent phenome-
non could be explained by sampling bias or the metastatic
potential of individual carcinoma cells.
Compared with IT carcinomas, the MT counterpart
always exhibited more severe characteristics, including
invasion into muscularis propria, lymphatic invasion and
lymph node metastasis, and high TNM staging in the
present study, as observed by Lauren and other studies [16,
26, 30]. To clarify the pheno/genotypes of gastric carcino-
ma, the expression of Ki-67, caspase-3, p53, FHIT, maspin,
VEGF, EMMPRIN, P-GSK3β-ser
9,M U C - 2 ,M U C - 4 ,
MUC-5AC, MUC-6, E-cadherin, and β-catenin was exam-
ined by immunostaining. p53, FHIT, and maspin as tumor
suppressor genes play important roles in regulating the
balance between the proliferation and apoptosis of cancer
cells [25, 30, 31, 34, 35]. Ki-67 antigen is present in the
nuclei of cells undergoing proliferation and should be
regarded as a good marker for cell proliferation [34].
Caspase-3 is responsible for the cleavage of poly (ADP-
ribose) polymerase, actin, and sterol regulatory element
binding protein and reflects the apoptotic level as a key
protease in the cascade reaction of the apoptotic pathway
[28]. In vivo and vitro evidences indicated that EMMPRIN
and VEGF are involved in angiogenic processes in
malignancies [29, 32]. Glycogen synthase kinase-3β
(GSK3β) belongs to the serine/threonine protein kinase
family and is also involved in regulating the balance
between proliferation and apoptosis and can be inactivated
via ser-9 phosphorylation by p70 S6 kinase, p90Rsk, Akt,
certain isoforms of proteins kinase, and cyclic AMP-
dependent protein kinase [1]. MUC-2, MUC-5AC, and
MUC-6 are markers for intestinal goblet cells, superficial
epithelium, and gastric pyloric gland cells, respectively,
which can reflect the mucin secretion and variations in
gastrointestinal malignancies. MUC-4 is a heterodimeric
glycoprotein complex and expressed in several human
epithelial carcinomas [3, 33]. CD44 is a cell surface
glycoprotein involved in cell/cell and cell/matrix interac-
tions. CD44 overexpression has been linked to the growth
and spread of a range of different types of malignancies [8].
The E-cadherin can interact with β-catenin to form a
complex, which is closely linked to cell adhesion and
differentiation [19, 27, 36]. In the present study, all of the
markers except MUC-5AC showed greater expression in
the IT than in the DTcarcinomas. Although some evidences
indicate that MUC-5AC was strongly expressed in gastric
DT carcinoma, in comparison with IT ones, there was no
statistical difference in line with our finding [20, 22]. These
data suggested that there were significant differences in the
proliferation, apoptosis, angiogenesis, mucin production,
and cell adhesion between the IT and DT carcinomas and
these molecules mechanistically contributed to the molecular
distinction in the morphological, behavioral, and histogenic
aspects between both types of gastric carcinomas.
In general, DT carcinoma is believed to derive de novo
from the peripheral stem cells of gastric gland neck
proliferative zone without a recognizable precursor lesion
except hereditary diffuse gastric cancer because in situ
carcinoma or globoid dysplasia is its precancerous lesion,
respectively, according to the Chinese and Western pathol-
ogists' opinions [4, 5, 9, 18,30]. When long-standing gastric
inflammation causes tissue injury and stem cell failure with
time, BMDCs are recruited and engrafted into the tissue
stem cell niche, where BMDCs can behave in a way
indistinguishable from endogenous tissue stem cells. With
continued inflammation and injury, they can undergo
sustained proliferation and malignant transformation into
IT carcinomas, passing through precancerous stages of
metaplasia and dysplasia when genetic defects, such as
mutation, deletion, or rearrangement, are accumulated
resulting in corruption of the balance between proliferation
and apoptosis [17]. Likewise, dedifferentiation of intestinal
to diffuse carcinoma had been identified as another
histogenic pathway according to the histological heteroge-
neity of tumor cells, especially in the carcinomas containing
moderately and poorly differentiated components with
similar morphological appearance and diffuse distribution.
If so, it is possible that the distinct components in MT
carcinomas arise from the stem cells with common genetic
traits and follow different carcinogenic pathways. Con-
versely, diffuse carcinoma could be derived from heteroge-
neity of the intestinal counterpart. According to our present
data, no differences in the expression of Ki-67, caspase-3,
FHIT, CD44, P-GSK3β-ser
9, MUC-2, MUC-5AC, MUC-6,
and membrane β-catenin were observed between the
intestinal and diffuse components of MT carcinomas, which
supports the possibility of similar origin or dedifferentia-
Table 5 Multivariate analysis of the clinicopathological variables of
gastric carcinomas
Clinicopathological parameters Relative risk
(95% CI)
p Value
Age (≥65 years) 1.224 (0.849–1.764) >0.05
Sex (male:female) 1.255 (0.827–1.904) >0.05
Tumor size (≥4 cm) 1.466 (0.862–2.493) >0.05
Invasive depth (Tis,1/T2,3) 2.945 (1.533–5.657) <0.05
Lymphatic invasion (−/+) 1.394 (0.865–2.247) >0.05
Venous invasion (−/+) 1.692 (1.097–2.608) <0.05
Lymph node metastasis (−/+) 1.983 (1.111–3.537) <0.05
Peritoneal spread (−/+) 3.197 (2.031–5.031) <0.05
Liver metastasis (−/+) 5.248 (2.575–10.697) <0.05
Lauren's classification
(intestinal/diffuse/mixed)
1.351 (1.084–1.683) <0.05
CI Confidence interval
532 Virchows Arch (2008) 452:525–534tion. However, increased expression of EMMPRIN, VEGF,
MUC-4, and E-cadherin in the intestinal component compared
to the diffuse counterpart also provided evidence that the
original carcinoma cells might undergo distinct carcinogenic
routes resulting in the morphological distinction of both
components. Both the intestinal and diffuse components in
MT carcinomas had increased expression of Ki-67, EMM-
PRIN, and VEGF and reduced E-cadherin. Serum VEGF
levelswerefoundtobesignificantlyhigherinpatientswithMT
gastric carcinomas than those with pure lesions [10]. It was
proposed that MT carcinomas biologically displayed more
aggressive behaviors than other types, including decreased
cell adhesion, increased proliferation, and angiogenesis.
Most of the evidences in the present data indicated that
the pathological behaviors of MT carcinomas were more
aggressive than the other types, which was closely linked to
the prognosis. It was previously documented that the MT
patients' survival is significantly worse than those with IT
or DT carcinomas regardless of their location [5]. However,
this study demonstrated that there was no significance
between the MT and DT carcinoma patients' survival rates
although the former was lower than the latter. Additionally,
both survival rates were lower than that with IT carcinomas.
To avoid sampling bias from a shorter follow-up time, the
older cases were chosen for the survival analysis, but they
yielded consistent results. Furthermore, Cox's hazard
proportional analysis indicated that the invasive depth,
venous invasion, lymph node, peritoneal or liver metastasis,
and Lauren's classification were independent prognostic
factors for gastric carcinomas.
In summary, IT carcinoma, which is positively correlated
with favorable prognosis, frequently displayed high levels
of proliferation, apoptosis, angiogenesis, mucin production,
and cell adhesion. Gastric MT carcinoma showed more
aggressive behaviors than IT and DT ones. There was a
significant difference in the proliferation, apoptosis, angio-
genesis, mucin secretion, and cell adhesion between the IT
and DT carcinomas, whereas only a few characteristics
were differentially detected in the intestinal and diffuse
component of the mixed-type carcinoma, suggesting that
different components of MT carcinoma might originate
from common stem cells, but follow distinct histogenic
pathways. Furthermore, these results confirm that Lauren's
classification is significant regarding the histopathogenesis
and differentiation and considered as a guide to the clinical
treatment of gastric carcinoma.
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